Malignant change occurring at the site
D J Sherlock, V Suarez, J G Gray Abstract Malignant change occurring at the site of a stoma in two patients with proved Crohn's disease is described. Patients with ulcerative colitis have an increased risk of colonic malignancy and Crohn's disease is also associated with both smali and large bowel carcinoma. Most previous reports of stomal carcinoma have been associated with ulcerative colitis although Crohn's disease seems to carry a greater risk of associated small bowel carcinomas. This is the first report of stomal carcinoma complicating Crohn's disease. Epithelial dysplasia is associated with gastrointestinal carcinomas in both ulcerative colitis and Crohn's disease and a dysplasia-carcinoma sequence has been suggested as the origin of these tumours. In both our patients with stomal adenocarcinoma, dysplasia was identified in adjacent tissues, which suggests a similar mechanism. Malignant change should be suspected if epithelial dysplasia is discovered in a biopsy specimen from the mucosa of an ileostomy in Crohn's disease, and this risk is increased if the dysplasia is of a high grade. Patient ic-Qss t)0ow the ileostomy wl-iP A -> i a, i) a{ll 1 ;'-ioillh 1 be a granuloma, but f'i twi')Si7 "; :8 iowdAit to be a mucinsecc'-'--.ih i ;t'! rI; ; c J I-(I' (Fig 3) . A Carcinoma of the ileum has been associated with both inflammatory bowel disease and polyposis coli. On two occasions patients with ulcerative colitis have been reported to have ileal carcinomas; both also had severe longstanding colitis with premalignant changes in the colon and backwash ileitis.25 26 Polyposis coli is associated with carcinoma of the duodenum and ileum,27 but there have been more reports of Crohn's disease associated with carcinoma of the ileum,28 particularly if an exclusion bypass has been performed. 24 One reason that stomal carcinoma more commonly complicates ulcerative colitis than Crohn's is that ileostomies are more frequently fashioned for ulcerative colitis and polyposis, while such a procedure is relatively contraindicated in Crohn's disease. Different or additional aetiological factors may operate to produce malignant change in exposed mucosa of an ileostomy in comparison with the intraperitoneal ileum. Firstly, the exposed mucocutaneous junction of a stoma is subject to both physical and chemical injury from the stoma appliance, cleaning agents, adhesives, and creams used to protect the skin or, conversely, the skin may be inadequately protected and subject to longterm excoriation from the ileostomy effluent.
Secondly, the intestinal flora in patients with ileostomies is affected29 and it is possible that a combination of these potential carcinogenic agents could, over a period of 20 years, induce malignant change. ' Epithelial dysplasia in a patient with ulcerative colitis is known to be associated with a high risk of colorectal carcinoma, and this has been utilised in cancer surveillance programmes. 30 Intestinal carcinoma associated with Crohn's disease has also been associated with similar dysplastic changes but this occurs only adjacent to the tumour and is less pronounced.2 Despite the absence of more distant dysplasia, so essentially precluding its use as a surveillance marker, the consistent association of carcinoma with dysplasia in Crohn's indicates a dysplasiacarcinoma sequence origin for these tumours. 2 31 Dysplasia was noted in the adjacent tissue of both patients with stomal carcinoma reported here, and this suggests that the origin of these cancers was similar. The presence of dysplasia in a biopsy specimen of an ileostomy in Crohn's disease would seem to be a useful indicator of a possible coexistent malignant lesion.
As in both our patients, the diagnosis is frequently delayed as these lesions are commonly thought to be granulomas and treated as such by cauterisation until recurrence occurs and a biopsy is performed. Review of the now 22 reported cases of ileostomy carcinoma suggests that overall the prognosis is favourable.5I21 The mean age of patients at presentation is 56 (range 39 to 79) years with a stoma having been present for a mean of 26 (range 3 to 38) years. By far the majority (17) occurred in patients who had been treated for ulcerative colitis, only three were in patients with polyposis coli and we report the only two cases in association with Crohn's disease. The long lead time suggests that the tumour is predominantly slow growing, only six patients have developed proved metastatic spread and all of these had moderate or poorly differentiated tumours. Four of these patients have died of carcinomatosis as a result of the stomal carcinoma, the remaining patients have apparently all been cured by local excision, although the length of follow up is inadequate in most reports and recurrent disease must have occurred in a proportion. Despite this, local excision is a successful treatment for these tumours, although the extent of the surgical excision varies between reports, some being more radical than others, requiring insertion of a mesh prosthesis to strengthen the resulting anterior abdominal wall defect. It is apparent from these results that the surgical treatment should include a wide local excision of the tissues of the anterior abdominal wall, with a limited resection of the ileum and refashioning of an ileostomy at a new site. Experience with our second patient also suggests that a careful excision of all mucosa is advisable when a stoma is refashioned or closed to prevent the future development of malignant change.
Epithelial hyperplasia, lymphoid nodules, and squamous metaplasia are all consequences of ileostomy irritation32 and are regularly seen in surgical outpatients and treated by cauterisation, biopsy rarely being performed. We suggest that biopsy specimens be taken of all persistent lesions on stoma, particularly ileostomies, before cauterisation. The presence of epithelial dysplasia seems to be a useful histological precursor of malignant change. Follow up of all patients with ileostomies is advisable, with annual examination of the stoma without the appliance to detect mucosal abnormalities.
